Related Experiment Video
Updated: Jul 29, 2026

Invasive Hemodynamic Characterization of the Portal-hypertensive Syndrome in Cirrhotic Rats
Published on: August 1, 2018
[Hepatopulmonary syndrome: relationship with liver dysfunction and systemic hemodynamic disorder]
José Luis Alonso Martínez1, José Manuel Zozaya Urmeneta, José Luis García Sanchotena
1Servicio de Medicina Interna, Hospital de Navarra, Pamplona, Navarra, Spain. jalonsom@cfnavarra.es
Hepatopulmonary syndrome (HPS) in liver cirrhosis involves systemic vasodilation, leading to hypoxemia and altered hemodynamics. This condition correlates with liver dysfunction severity and increased nitric oxide production.
Area of Science:
- Cardiology
- Pulmonology
- Hepatology
Context:
- Hepatopulmonary syndrome (HPS) is characterized by impaired gas exchange in liver cirrhosis due to pulmonary vasodilation.
- Systemic vasodilation is a known complication of liver cirrhosis, affecting various vascular beds.
Purpose:
- To investigate the hemodynamic status, renal function, and humoral systems in cirrhotic patients with HPS.
- To correlate HPS severity with liver dysfunction and systemic vasodilation.
Summary:
- 32 cirrhotic patients were divided into groups with normal gaseous exchange (NGE) and HPS.
- HPS patients exhibited advanced Child-Pugh scores, hypoxemia, hypocapnia, and a hyperkinetic circulatory state.
- These patients also showed impaired renal function, increased plasma volume, activated renin-angiotensin-aldosterone system, and elevated nitrite/nitrate excretion.
Impact:
- Pulmonary vasodilation in HPS is integral to the systemic vasodilation of liver cirrhosis.
- HPS severity is linked to the degree of liver dysfunction.
- Increased nitric oxide production contributes to arterial underfilling and plasma volume expansion in HPS.
Related Concept Videos
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Cirrhosis II: Pathophysiology
Portal Hypertension
Hepatic Encephalopathy

